167 related articles for article (PubMed ID: 18953273)
21. Response to "key amprenavir resistance mutations counteract dramatic efficacy of darunavir in highly experienced patients".
Picchio G; De Meyer S; de Béthune MP
AIDS; 2008 Jan; 22(1):165-7. PubMed ID: 18090413
[No Abstract] [Full Text] [Related]
22. Tipranavir.
Flexner C; Bate G; Kirkpatrick P
Nat Rev Drug Discov; 2005 Dec; 4(12):955-6. PubMed ID: 16370086
[No Abstract] [Full Text] [Related]
23. HIV protease inhibitors: recent clinical trials and recommendations on use.
Fernández-Montero JV; Barreiro P; Soriano V
Expert Opin Pharmacother; 2009 Jul; 10(10):1615-29. PubMed ID: 19527188
[TBL] [Abstract][Full Text] [Related]
24. [Resistance to darunavir].
García Deltoro M
Enferm Infecc Microbiol Clin; 2008 Oct; 26 Suppl 10():51-60. PubMed ID: 19195460
[TBL] [Abstract][Full Text] [Related]
25. Resilience to resistance of HIV-1 protease inhibitors: profile of darunavir.
Lefebvre E; Schiffer CA
AIDS Rev; 2008; 10(3):131-42. PubMed ID: 18820715
[TBL] [Abstract][Full Text] [Related]
26. Darunavir in the treatment of HIV-1 infection: a viewpoint by Mark Holodniy.
Holodniy M
Drugs; 2007; 67(18):2803. PubMed ID: 18062725
[No Abstract] [Full Text] [Related]
27. Efficacy and safety of darunavir/ritonavir plus etravirine dual regimen in antiretroviral therapy-experienced patients: a multicenter clinical experience.
Gazzola L; Cicconi P; Ripamonti D; Di Filippo E; Gustinetti G; Di Biagio A; Marchetti G; Bini T; d'Arminio Monforte A
HIV Clin Trials; 2014; 15(4):140-50. PubMed ID: 25143023
[TBL] [Abstract][Full Text] [Related]
28. [HIV infection. Compatibility of recent protease inhibitors in direct comparison - the advantage of DRV].
MMW Fortschr Med; 2014 Jun; 156 Suppl 1():52. PubMed ID: 25026859
[No Abstract] [Full Text] [Related]
29. Anti-HIV agents. Darunavir shows its strength.
TreatmentUpdate; 2007; 19(5):2-4. PubMed ID: 17955613
[No Abstract] [Full Text] [Related]
30. FDA approves tipranavir.
IAPAC Mon; 2005 Jul; 11(7):190. PubMed ID: 16676422
[No Abstract] [Full Text] [Related]
31. New therapeutic agents in the management of HIV: an overview of darunavir for clinicians.
Rotty J; Hoy J
Sex Health; 2008 Sep; 5(3):235-41. PubMed ID: 18771638
[TBL] [Abstract][Full Text] [Related]
32. New resistance score for tipranavir.
Poveda E
AIDS Rev; 2008; 10(2):127. PubMed ID: 18615125
[No Abstract] [Full Text] [Related]
33. New protease inhibitor offers clinicians hope for better salvage therapy.
Murphy MJ
HIV Clin; 2006; 18(1):1-3. PubMed ID: 16838417
[No Abstract] [Full Text] [Related]
34. [Perspectives: hope for therapy experienced patients. Tipranavir shows superior effectiveness with comparable safety].
MMW Fortschr Med; 2005 Apr; 147 Spec No 1():44-5. PubMed ID: 16385873
[No Abstract] [Full Text] [Related]
35. The influence of protease inhibitor resistance profiles on selection of HIV therapy in treatment-naive patients.
Turner D; Schapiro JM; Brenner BG; Wainberg MA
Antivir Ther; 2004 Jun; 9(3):301-14. PubMed ID: 15259893
[TBL] [Abstract][Full Text] [Related]
36. Tipranavir: a novel non-peptidic protease inhibitor for the treatment of HIV infection.
Mehandru S; Markowitz M
Expert Opin Investig Drugs; 2003 Nov; 12(11):1821-8. PubMed ID: 14585057
[TBL] [Abstract][Full Text] [Related]
37. [Desensitization to tipranavir caused by toxicodermia].
Martínez Castro B; Ferrando Piqueres R; Martínez García M; Soler Company E
Farm Hosp; 2009; 33(6):340-2. PubMed ID: 20038397
[No Abstract] [Full Text] [Related]
38. Tipranavir.
Gallant J
Drugs; 2003; 63(15):1619-20. PubMed ID: 12887269
[No Abstract] [Full Text] [Related]
39. Etravirine in combination with darunavir/ritonavir and optimized background regimen results in suppression of HIV replication in treatment-experienced patients. Evaluation of Katlama C, Haubrich R, Lalezari J, et al. Efficacy and safety of etravirine in treatment-experienced HIV-1 patients: pooled 48-week analysis of two randomized, controlled trials. AIDS 2009; 23: 2289-300.
Hull MW; Montaner JS
Expert Opin Pharmacother; 2010 Jun; 11(8):1433-7. PubMed ID: 20367279
[TBL] [Abstract][Full Text] [Related]
40. Darunavir in the treatment of HIV-1 infection: a viewpoint by Renslow Sherer.
Sherer R
Drugs; 2007; 67(18):2802-3. PubMed ID: 18062726
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
